NCT05558124 2026-02-27CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AMLH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Recruiting18 enrolled
NCT06448013 2025-12-15A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid LeukemiaM.D. Anderson Cancer CenterPhase 1 Recruiting22 enrolled